nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—IL3—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.0429	0.126	CbGpPWpGaD
Amlexanox—PDE4C—tongue—hypothyroidism	0.042	0.0636	CbGeAlD
Amlexanox—IL3—Differentiation Pathway—TPO—hypothyroidism	0.0371	0.109	CbGpPWpGaD
Amlexanox—FGF1—nerve—hypothyroidism	0.0354	0.0536	CbGeAlD
Amlexanox—IL3—blood—hypothyroidism	0.0335	0.0508	CbGeAlD
Amlexanox—S100A13—heart—hypothyroidism	0.0213	0.0323	CbGeAlD
Amlexanox—S100A12—heart—hypothyroidism	0.021	0.0319	CbGeAlD
Amlexanox—S100A13—cardiovascular system—hypothyroidism	0.0201	0.0305	CbGeAlD
Amlexanox—S100A12—cardiovascular system—hypothyroidism	0.0198	0.0301	CbGeAlD
Amlexanox—S100A13—gonad—hypothyroidism	0.0183	0.0277	CbGeAlD
Amlexanox—S100A12—pituitary gland—hypothyroidism	0.0176	0.0266	CbGeAlD
Amlexanox—PDE4D—TSH signaling pathway—PAX8—hypothyroidism	0.017	0.0501	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—TPO—hypothyroidism	0.017	0.0499	CbGpPWpGaD
Amlexanox—S100A13—adrenal gland—hypothyroidism	0.0159	0.0241	CbGeAlD
Amlexanox—S100A12—adrenal gland—hypothyroidism	0.0157	0.0238	CbGeAlD
Amlexanox—S100A12—blood—hypothyroidism	0.0157	0.0238	CbGeAlD
Amlexanox—S100A13—thyroid gland—hypothyroidism	0.0154	0.0233	CbGeAlD
Amlexanox—S100A13—female gonad—hypothyroidism	0.0148	0.0225	CbGeAlD
Amlexanox—S100A12—female gonad—hypothyroidism	0.0146	0.0222	CbGeAlD
Amlexanox—PDE4D—heart—hypothyroidism	0.014	0.0213	CbGeAlD
Amlexanox—S100A13—testis—hypothyroidism	0.0132	0.0199	CbGeAlD
Amlexanox—FGF1—heart—hypothyroidism	0.0131	0.0199	CbGeAlD
Amlexanox—S100A12—testis—hypothyroidism	0.013	0.0197	CbGeAlD
Amlexanox—S100A13—liver—hypothyroidism	0.0124	0.0189	CbGeAlD
Amlexanox—PDE4A—heart—hypothyroidism	0.0124	0.0188	CbGeAlD
Amlexanox—FGF1—cardiovascular system—hypothyroidism	0.0124	0.0188	CbGeAlD
Amlexanox—S100A12—liver—hypothyroidism	0.0123	0.0186	CbGeAlD
Amlexanox—S100A13—cerebellum—hypothyroidism	0.0122	0.0184	CbGeAlD
Amlexanox—FGF1—pituitary gland—hypothyroidism	0.011	0.0166	CbGeAlD
Amlexanox—PDE4D—adrenal gland—hypothyroidism	0.0105	0.0159	CbGeAlD
Amlexanox—IL3—GPVI-mediated activation cascade—VAV3—hypothyroidism	0.0103	0.0304	CbGpPWpGaD
Amlexanox—PDE4D—thyroid gland—hypothyroidism	0.0101	0.0153	CbGeAlD
Amlexanox—FGF1—adrenal gland—hypothyroidism	0.0098	0.0148	CbGeAlD
Amlexanox—FGF1—blood—hypothyroidism	0.0098	0.0148	CbGeAlD
Amlexanox—PDE4D—female gonad—hypothyroidism	0.00977	0.0148	CbGeAlD
Amlexanox—FGF1—thyroid gland—hypothyroidism	0.00945	0.0143	CbGeAlD
Amlexanox—PDE4A—adrenal gland—hypothyroidism	0.00927	0.014	CbGeAlD
Amlexanox—FGF1—female gonad—hypothyroidism	0.00914	0.0138	CbGeAlD
Amlexanox—PDE4A—thyroid gland—hypothyroidism	0.00894	0.0136	CbGeAlD
Amlexanox—PDE4D—testis—hypothyroidism	0.00866	0.0131	CbGeAlD
Amlexanox—PDE4A—female gonad—hypothyroidism	0.00864	0.0131	CbGeAlD
Amlexanox—PDE4D—liver—hypothyroidism	0.00819	0.0124	CbGeAlD
Amlexanox—FGF1—testis—hypothyroidism	0.0081	0.0123	CbGeAlD
Amlexanox—PDE4D—cerebellum—hypothyroidism	0.008	0.0121	CbGeAlD
Amlexanox—PDE4A—testis—hypothyroidism	0.00767	0.0116	CbGeAlD
Amlexanox—FGF1—liver—hypothyroidism	0.00766	0.0116	CbGeAlD
Amlexanox—FGF1—cerebellum—hypothyroidism	0.00748	0.0113	CbGeAlD
Amlexanox—PDE4D—TSH signaling pathway—TSHB—hypothyroidism	0.00742	0.0218	CbGpPWpGaD
Amlexanox—PDE4D—TSH signaling pathway—TSHR—hypothyroidism	0.00742	0.0218	CbGpPWpGaD
Amlexanox—PDE4B—heart—hypothyroidism	0.0074	0.0112	CbGeAlD
Amlexanox—PDE4A—cerebellum—hypothyroidism	0.00708	0.0107	CbGeAlD
Amlexanox—IL3—Differentiation Pathway—IGF1—hypothyroidism	0.00647	0.019	CbGpPWpGaD
Amlexanox—FGF1—FGF signaling pathway—BGLAP—hypothyroidism	0.00642	0.0189	CbGpPWpGaD
Amlexanox—PDE4B—gonad—hypothyroidism	0.00634	0.00961	CbGeAlD
Amlexanox—PDE4B—pituitary gland—hypothyroidism	0.00619	0.00938	CbGeAlD
Amlexanox—PDE4B—adrenal gland—hypothyroidism	0.00553	0.00838	CbGeAlD
Amlexanox—PDE4B—blood—hypothyroidism	0.00553	0.00837	CbGeAlD
Amlexanox—PDE4B—thyroid gland—hypothyroidism	0.00533	0.00808	CbGeAlD
Amlexanox—PDE4B—female gonad—hypothyroidism	0.00515	0.00781	CbGeAlD
Amlexanox—PDE4C—G alpha (s) signalling events—TSHR—hypothyroidism	0.00515	0.0151	CbGpPWpGaD
Amlexanox—PDE4C—G alpha (s) signalling events—TSHB—hypothyroidism	0.00515	0.0151	CbGpPWpGaD
Amlexanox—PDE4B—testis—hypothyroidism	0.00457	0.00693	CbGeAlD
Amlexanox—PDE4D—G alpha (s) signalling events—TSHB—hypothyroidism	0.00448	0.0132	CbGpPWpGaD
Amlexanox—PDE4D—G alpha (s) signalling events—TSHR—hypothyroidism	0.00448	0.0132	CbGpPWpGaD
Amlexanox—PDE4B—liver—hypothyroidism	0.00432	0.00655	CbGeAlD
Amlexanox—PDE4A—G alpha (s) signalling events—TSHB—hypothyroidism	0.00427	0.0125	CbGpPWpGaD
Amlexanox—PDE4A—G alpha (s) signalling events—TSHR—hypothyroidism	0.00427	0.0125	CbGpPWpGaD
Amlexanox—PDE4B—cerebellum—hypothyroidism	0.00422	0.0064	CbGeAlD
Amlexanox—PDE4B—G alpha (s) signalling events—TSHB—hypothyroidism	0.00395	0.0116	CbGpPWpGaD
Amlexanox—PDE4B—G alpha (s) signalling events—TSHR—hypothyroidism	0.00395	0.0116	CbGpPWpGaD
Amlexanox—IL3—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.00346	0.0102	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.0031	0.0091	CbGpPWpGaD
Amlexanox—PDE4C—G alpha (s) signalling events—AVP—hypothyroidism	0.00303	0.00892	CbGpPWpGaD
Amlexanox—FGF1—Differentiation Pathway—IGF1—hypothyroidism	0.00296	0.00871	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.00296	0.0087	CbGpPWpGaD
Amlexanox—PDE4C—Opioid Signalling—POMC—hypothyroidism	0.00283	0.00833	CbGpPWpGaD
Amlexanox—FGF1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.00283	0.00833	CbGpPWpGaD
Amlexanox—IL3—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.00277	0.00814	CbGpPWpGaD
Amlexanox—PDE4D—G alpha (s) signalling events—AVP—hypothyroidism	0.00264	0.00776	CbGpPWpGaD
Amlexanox—PDE4A—G alpha (s) signalling events—AVP—hypothyroidism	0.00251	0.00739	CbGpPWpGaD
Amlexanox—PDE4D—Opioid Signalling—POMC—hypothyroidism	0.00247	0.00725	CbGpPWpGaD
Amlexanox—PDE4A—Opioid Signalling—POMC—hypothyroidism	0.00235	0.0069	CbGpPWpGaD
Amlexanox—PDE4B—G alpha (s) signalling events—AVP—hypothyroidism	0.00233	0.00684	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—SH2B3—hypothyroidism	0.00232	0.00683	CbGpPWpGaD
Amlexanox—PDE4B—Opioid Signalling—POMC—hypothyroidism	0.00217	0.00639	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00214	0.0063	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—PRL—hypothyroidism	0.00207	0.00608	CbGpPWpGaD
Amlexanox—PDE4C—G alpha (s) signalling events—POMC—hypothyroidism	0.00202	0.00593	CbGpPWpGaD
Amlexanox—IL3—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.00191	0.0056	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—TRH—hypothyroidism	0.00185	0.00544	CbGpPWpGaD
Amlexanox—FGF1—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.00181	0.00531	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—VAV3—hypothyroidism	0.0018	0.00529	CbGpPWpGaD
Amlexanox—IL3—Immune System—CLTC—hypothyroidism	0.00178	0.00522	CbGpPWpGaD
Amlexanox—FGF1—IGF1R signaling cascade—IGF1—hypothyroidism	0.00176	0.00518	CbGpPWpGaD
Amlexanox—PDE4D—G alpha (s) signalling events—POMC—hypothyroidism	0.00176	0.00516	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.00169	0.00498	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—VAV3—hypothyroidism	0.00169	0.00498	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—TRH—hypothyroidism	0.00168	0.00494	CbGpPWpGaD
Amlexanox—PDE4A—G alpha (s) signalling events—POMC—hypothyroidism	0.00167	0.00491	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—TSHB—hypothyroidism	0.00165	0.00485	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—TSHR—hypothyroidism	0.00165	0.00485	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—VAV3—hypothyroidism	0.0016	0.00469	CbGpPWpGaD
Amlexanox—PDE4B—G alpha (s) signalling events—POMC—hypothyroidism	0.00155	0.00454	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—TSHB—hypothyroidism	0.0015	0.0044	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—TSHR—hypothyroidism	0.0015	0.0044	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CLTC—hypothyroidism	0.00142	0.00418	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CLTC—hypothyroidism	0.00134	0.00394	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—TRH—hypothyroidism	0.00118	0.00348	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—VAV3—hypothyroidism	0.00115	0.00339	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—VAV3—hypothyroidism	0.00115	0.00338	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CLTC—hypothyroidism	0.00115	0.00337	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TRH—hypothyroidism	0.00108	0.00316	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—TSHB—hypothyroidism	0.00106	0.0031	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—TSHR—hypothyroidism	0.00106	0.0031	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—TRH—hypothyroidism	0.00103	0.00303	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—VAV3—hypothyroidism	0.00101	0.00296	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TRH—hypothyroidism	0.000992	0.00292	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—IGF1—hypothyroidism	0.000983	0.00289	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—TRH—hypothyroidism	0.000982	0.00289	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000981	0.00288	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—AVP—hypothyroidism	0.000972	0.00286	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TSHB—hypothyroidism	0.000959	0.00282	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—TSHR—hypothyroidism	0.000959	0.00282	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TRH—hypothyroidism	0.000937	0.00275	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—TSHB—hypothyroidism	0.000919	0.0027	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—TSHR—hypothyroidism	0.000919	0.0027	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—VAV3—hypothyroidism	0.000916	0.00269	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TRH—hypothyroidism	0.000908	0.00267	CbGpPWpGaD
Amlexanox—IL3—Immune System—PRL—hypothyroidism	0.000904	0.00266	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TRH—hypothyroidism	0.000892	0.00262	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TSHB—hypothyroidism	0.000884	0.0026	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TSHR—hypothyroidism	0.000884	0.0026	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—AVP—hypothyroidism	0.000882	0.00259	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—TSHB—hypothyroidism	0.000875	0.00257	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—TSHR—hypothyroidism	0.000875	0.00257	CbGpPWpGaD
Amlexanox—IL3—Immune System—VAV3—hypothyroidism	0.000837	0.00246	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TSHB—hypothyroidism	0.000835	0.00245	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—TSHR—hypothyroidism	0.000835	0.00245	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TRH—hypothyroidism	0.000825	0.00243	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CLTC—hypothyroidism	0.000813	0.00239	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TSHB—hypothyroidism	0.00081	0.00238	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—TSHR—hypothyroidism	0.00081	0.00238	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TSHB—hypothyroidism	0.000795	0.00234	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—TSHR—hypothyroidism	0.000795	0.00234	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SH2B3—hypothyroidism	0.000788	0.00232	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CLTC—hypothyroidism	0.000735	0.00216	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TSHB—hypothyroidism	0.000735	0.00216	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—TSHR—hypothyroidism	0.000735	0.00216	CbGpPWpGaD
Amlexanox—S100A12—Immune System—PRL—hypothyroidism	0.000725	0.00213	CbGpPWpGaD
Amlexanox—S100A12—Immune System—VAV3—hypothyroidism	0.000671	0.00197	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—VAV3—hypothyroidism	0.000658	0.00193	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—VAV3—hypothyroidism	0.000646	0.0019	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—POMC—hypothyroidism	0.000646	0.0019	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CLTC—hypothyroidism	0.00064	0.00188	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TRH—hypothyroidism	0.000636	0.00187	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—AVP—hypothyroidism	0.000622	0.00183	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CLTC—hypothyroidism	0.000609	0.00179	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—VAV3—hypothyroidism	0.000587	0.00172	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—POMC—hypothyroidism	0.000586	0.00172	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—PRL—hypothyroidism	0.000585	0.00172	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TSHR—hypothyroidism	0.000567	0.00167	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TSHB—hypothyroidism	0.000567	0.00167	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—AVP—hypothyroidism	0.000565	0.00166	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CLTC—hypothyroidism	0.000564	0.00166	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—VAV3—hypothyroidism	0.000562	0.00165	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TRH—hypothyroidism	0.000553	0.00163	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—AVP—hypothyroidism	0.000542	0.00159	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VAV3—hypothyroidism	0.000541	0.00159	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—VAV3—hypothyroidism	0.000535	0.00157	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TRH—hypothyroidism	0.000527	0.00155	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CLTC—hypothyroidism	0.000526	0.00155	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—AVP—hypothyroidism	0.000521	0.00153	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—AVP—hypothyroidism	0.000516	0.00152	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—VAV3—hypothyroidism	0.000511	0.0015	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SH2B3—hypothyroidism	0.000505	0.00148	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—VAV3—hypothyroidism	0.000495	0.00146	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TSHB—hypothyroidism	0.000493	0.00145	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TSHR—hypothyroidism	0.000493	0.00145	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—AVP—hypothyroidism	0.000492	0.00145	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TRH—hypothyroidism	0.000487	0.00143	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—VAV3—hypothyroidism	0.000486	0.00143	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—AVP—hypothyroidism	0.000477	0.0014	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TSHB—hypothyroidism	0.000469	0.00138	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TSHR—hypothyroidism	0.000469	0.00138	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—AVP—hypothyroidism	0.000468	0.00138	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TRH—hypothyroidism	0.000454	0.00134	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—VAV3—hypothyroidism	0.00045	0.00132	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SH2B3—hypothyroidism	0.00044	0.00129	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TSHB—hypothyroidism	0.000434	0.00128	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TSHR—hypothyroidism	0.000434	0.00128	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—AVP—hypothyroidism	0.000433	0.00127	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SH2B3—hypothyroidism	0.000418	0.00123	CbGpPWpGaD
Amlexanox—FGF1—Immune System—PRL—hypothyroidism	0.000414	0.00122	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—POMC—hypothyroidism	0.000414	0.00122	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TSHR—hypothyroidism	0.000405	0.00119	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TSHB—hypothyroidism	0.000405	0.00119	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SH2B3—hypothyroidism	0.000387	0.00114	CbGpPWpGaD
Amlexanox—FGF1—Immune System—VAV3—hypothyroidism	0.000383	0.00113	CbGpPWpGaD
Amlexanox—FGF1—Disease—PRL—hypothyroidism	0.000382	0.00112	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—POMC—hypothyroidism	0.000376	0.0011	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PRL—hypothyroidism	0.000375	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SH2B3—hypothyroidism	0.000361	0.00106	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—POMC—hypothyroidism	0.00036	0.00106	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VAV3—hypothyroidism	0.000347	0.00102	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—POMC—hypothyroidism	0.000346	0.00102	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—POMC—hypothyroidism	0.000343	0.00101	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—AVP—hypothyroidism	0.000334	0.000982	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—IGF1—hypothyroidism	0.000333	0.000979	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—POMC—hypothyroidism	0.000327	0.000961	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PRL—hypothyroidism	0.000326	0.000959	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—POMC—hypothyroidism	0.000317	0.000932	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—POMC—hypothyroidism	0.000311	0.000915	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PRL—hypothyroidism	0.00031	0.000913	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VAV3—hypothyroidism	0.000302	0.000887	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—AVP—hypothyroidism	0.000291	0.000855	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—POMC—hypothyroidism	0.000288	0.000847	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PRL—hypothyroidism	0.000287	0.000844	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VAV3—hypothyroidism	0.000287	0.000844	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—AVP—hypothyroidism	0.000277	0.000813	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PRL—hypothyroidism	0.000268	0.000787	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VAV3—hypothyroidism	0.000266	0.000781	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—AVP—hypothyroidism	0.000256	0.000753	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VAV3—hypothyroidism	0.000248	0.000728	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—AVP—hypothyroidism	0.000239	0.000702	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—POMC—hypothyroidism	0.000222	0.000652	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—IGF1—hypothyroidism	0.000213	0.000628	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—POMC—hypothyroidism	0.000193	0.000568	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—IGF1—hypothyroidism	0.000186	0.000546	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—POMC—hypothyroidism	0.000184	0.000541	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—IGF1—hypothyroidism	0.000177	0.00052	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—POMC—hypothyroidism	0.00017	0.0005	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—IGF1—hypothyroidism	0.000164	0.000481	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—POMC—hypothyroidism	0.000159	0.000466	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—IGF1—hypothyroidism	0.000153	0.000449	CbGpPWpGaD
